Evolus EOLS
NASDAQ EOLS
$8.01 +0.02 (+0.25%)
As of: Sep 30, 2026 · 3:59 PM EDT

Evolus (EOLS) Short term Debt (2020)

Updated

Evolus' Short term Debt was $74.38 million in Q4 2020.

Analysis

Evolus (EOLS) Short term Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Evolus 527.45 Mn 335.14 Mn 57.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 74.38 Mn
API Access

Evolus Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=EOLS&period=max&api_key=YOUR_API_KEY